Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

DiaSorin SpA

34D
Current price
100.5 EUR 0 EUR (0.00%)
Last closed 104.6 EUR
Company
ISIN IT0003492391
Sector Healthcare
Industry Diagnostics & Research
Exchange Berlin Exchange
Capitalization 5 747 711 281 EUR
Yield for 12 month +19.33 %
1Y
3Y
5Y
10Y
15Y
34D
21.11.2021 - 28.11.2021

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy. Address: Via Crescentino, Saluggia, VC, Italy, 13040

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

33.7624

Dividend Yield

1.12 %

Current Year

+1 211 487 974 EUR

Last Year

+1 379 758 922 EUR

Current Quarter

+304 312 940 EUR

Last Quarter

+292 953 637 EUR

Current Year

+786 223 701 EUR

Last Year

+912 933 752 EUR

Current Quarter

+200 640 804 EUR

Last Quarter

+194 626 638 EUR

Key Figures 34D

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 330 535 782 EUR
Operating Margin TTM 23.09 %
PE Ratio 33.7624
Return On Assets TTM 4.69 %
PEG Ratio 1.4504
Return On Equity TTM 10.75 %
Wall Street Target Price
Revenue TTM 1 176 909 357 EUR
Book Value 30.72 EUR
Revenue Per Share TTM
Dividend Share 1.17 EUR
Quarterly Revenue Growth YOY 4.7 %
Dividend Yield 1.12 %
Gross Profit TTM 912 933 752 EUR
Earnings per share 3.07 EUR
Diluted Eps TTM 3.07 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 7.7 %
Profit Margin 14.45 %

Dividend Analytics 34D

Dividend growth over 5 years

-58 %

Continuous growth

3 years

Payout Ratio 5 years average

30 %

Dividend History 34D

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.15
Ex Dividend Date 20.05.2024
Forward Annual Dividend Yield 1.12 %
Last Split Factor
Payout Ratio 118.56 %
Last Split Date
Dividend Date

Stock Valuation 34D

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 33.7624
Forward PE 22.1729
Enterprise Value Revenue 5.5833
Price Sales TTM 4.8837
Enterprise Value EBITDA 17.1992
Price Book MRQ 3.3752

Financials 34D

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 34D

For 52 weeks

81.15 EUR 107.04 EUR
50 Day MA 103.04 EUR
Shares Short Prior Month
200 Day MA 96.3 EUR
Short Ratio
Shares Short
Short Percent